Cameco Corporation (CCJ) Stock Price & Analysis
Cameco Corporation (CCJ) closed at USD 78.93 on Thursday, October 22, 2026, down 3.77% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 82.02; the Oct 22, 2026 session ranged USD 78.27–80.46 on volume of 4,051,654 shares. Market capitalization is $34.38B, with a 52-week range of USD 77.7–135.24 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 09:21 UTC.
Also available as compact Markdown for AI agents: nexqual.com/CCJ.md
Key facts (CCJ)
- 1 of 80 tracked superinvestors hold CCJ (13F, Q2 2026): 0 new, 1 added, 0 reduced, 0 unchanged.
- Total return with dividends: 1Y -8.4% vs S&P 500 +14.9%; 5Y +208.2% vs S&P 500 +80.3%.
- Next earnings: 2026-10-30, EPS estimate USD 0.27, revenue estimate $754M.
Superinvestors (SEC 13F-HR, Q2 2026) (CCJ)
1 of 80 tracked investors hold CCJ. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Polen Capital | Polen Capital Management | 0.06% | $7.0M | Added +241.3% |
Analysts (CCJ)
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-22 | Truist Securities | Target lowered | Buy | $130 → $125 |
| 2026-10-19 | Barclays | Target lowered | Equal-Weight | $97 → $95 |
| 2026-08-12 | Truist Securities | Target raised | Buy | $129 → $130 |
| 2026-08-04 | Barclays | Target lowered | Equal-Weight | $104 → $97 |
| 2026-07-16 | Barclays | Target lowered | Equal-Weight | $108 → $104 |
| 2026-07-14 | Truist Securities | Initiated | Buy | $129 |
| 2026-07-09 | B of A Securities | Target lowered | Buy | $143 → $140 |
| 2026-06-29 | RBC Capital | Target raised | Outperform | $160 → $175 |
Total return (dividends reinvested) (CCJ)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | -8.4% | +208.2% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | -8.4% | +25.2% |
| Volatility (annualized) | 54.5% | 46.0% |
| Max drawdown | -41.1% (Jan 2026→Oct 2026) | -38.0% (Dec 2024→Mar 2025) |
Companies that name CCJ in their SEC reports
| Relationship to CCJ | Company | Filing | Sentence |
|---|---|---|---|
| partner | URANIUM ENERGY CORP (UEC) | 10-K Sep 29, 2026 | “In 1983, the Saskatchewan Mining and Development Corporation ("SMDC"), predecessor to Cameco, became the operator of the Dawn Lake Joint Venture.” |
| partner | enCore Energy Corp. (EU) | 10-K Mar 31, 2026 | “•Westinghouse Electric Company, Cameco Corporation, and Brookfield Asset Management have announced that the U.S. Government has entered into a strategic partnership to accelerate the deployment of nuclear power pursuant to Executive Orders issued by President Donald Trump on May 23, 2025.” |
| related | Brookfield Business Partners L.P. (BBUC) | 20-F Mar 31, 2026 | “In November 7, 2023, the partnership completed the sale of its nuclear technology services operation to a strategic consortium led by Cameco Corporation and Brookfield Renewable Partners, a related party to the partnership, for total consideration of $3.8 billion, net of transaction closing costs.” |
| partner | Brookfield Renewable Partners L.P. (BEPI) | 20-F Feb 27, 2026 | “Some of our investments and operations are structured as joint ventures, partnerships and consortium arrangements, including our investment in Isagen, our joint venture with Cameco for Westinghouse and our investment in Neoen.” |
| partner | Brookfield Renewable Corp (BEPC) | 20-F Feb 27, 2026 | “Some of our group's investments and operations are structured as joint ventures, partnerships and consortium arrangements, including its interest in Isagen, its joint venture with Cameco for Westinghouse and its investment in Neoen.” |
CCJ analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $0.27 | $0.35 | -22.6% | $753.9M | 13 |
| Next quarter (ends Dec 2026) | $0.56 | $0.53 | +6.3% | $1.09B | 9 |
| Current fiscal year (ends Dec 2026) | $1.45 | $1.67 | -13.6% | $3.48B | 18 |
| Next fiscal year (ends Dec 2027) | $2.66 | $2.69 | -1.1% | $4.02B | 17 |
CCJ options: expected move
Options price a move of about ±6.7% (±$5.28) by Oct 30, 2026, which includes earnings on Oct 30, 2026.
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Oct 30, 2026 | 7 | 56.4% | ±6.7% |
| Nov 6, 2026 | 14 | 52.8% | ±8.6% |
| Nov 13, 2026 | 21 | 53.9% | ±10.6% |
| Nov 20, 2026 | 28 | 48.4% | ±10.9% |
| Nov 27, 2026 | 35 | 46.8% | ±11.8% |
| Dec 4, 2026 | 42 | 43.6% | ±12.0% |
| Dec 18, 2026 | 56 | 45.1% | ±14.4% |
| Jan 15, 2027 | 84 | 45.8% | ±17.5% |
30-day implied volatility 47.8% vs 39.3% realized over the last 30 trading days. Put/call ratio (volume) 1.81. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 23, 2026 at 09:21 UTC)
| Price | USD 78.93 |
|---|---|
| Change | ▼ 3.77% (down) |
| Previous Close | USD 82.02 |
| Open | USD 79.65 |
| Day Range | USD 78.27 – 80.46 |
| 52-Week Range | USD 77.7 – 135.24 |
| Volume | 4,051,654 shares |
| Market Cap | $34.38B |
| Exchange | NYQ |
Technical Analysis (CCJ)
Nexqual's technical model rates CCJ "SELL" based on 1 bullish and 5 bearish signals across 127 daily candles, as of October 23, 2026 at 09:21 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 30.85 (neutral) |
| vs SMA50 | Below (USD 92.6) |
| MACD | -3.31 (negative) |
Earnings (CCJ)
| Next Earnings Date | 2026-10-30 |
|---|---|
| EPS Estimate | USD 0.27 |
| Revenue Estimate | $753.87M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.18 vs est 0.38 ▼ miss |
| 2026-03-31 | USD 0.47 vs est 0.34 ▲ beat |
| 2025-12-31 | USD 0.5 vs est 0.44 ▲ beat |
| 2025-09-30 | USD 0.07 vs est 0.27 ▼ miss |
Source: Nexqual, October 23, 2026 at 09:21 UTC.
Financials & Fundamentals (CCJ)
| Total Revenue | $3.47B |
|---|---|
| Revenue Growth (latest quarter, YoY) | -7.20% |
| Gross Margin | +35.11% |
| Operating Margin | +9.11% |
| Profit Margin | +10.21% |
| ROE | +5.11% |
| Debt / Equity | 0.17 |
| Current Ratio | 3.06 |
| Total Cash | $1.11B |
| Total Debt | $1.22B |
Source: Nexqual, October 23, 2026 at 09:21 UTC.
Financial Health Score (CCJ)
Nexqual rates Cameco Corporation's overall financial health "Solid" across five dimensions, as of October 23, 2026 at 09:21 UTC.
| Growth | Solid — Revenue +11% YoY (annual) |
|---|---|
| Profitability | Solid — Gross margin 35%, operating 9% (last 12 months) |
| Balance Sheet | Strong — CAD 1.11B cash vs CAD 1.22B debt |
| Cash Flow | Solid — Operating cash flow CAD 942M (TTM) |
| Efficiency | Mixed — ROE 5%, ROA 3.0% |
Ownership (CCJ)
| Insider Ownership | +0.14% |
|---|---|
| Institutional Ownership | +70.09% |
| Shares Outstanding | 435.53M |
| Float | 434.48M |
Source: Nexqual, October 23, 2026 at 09:21 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NXE | Nexgen Energy Ltd. | USD 8.1 | ▼ 5.04% |
| UEC | Uranium Energy Corp. | USD 7.48 | ▼ 5.32% |
| LEU | Centrus Energy Corp. | USD 104.15 | ▼ 4.37% |
| UUUU | Energy Fuels Inc | USD 7.69 | ▼ 6.22% |
| DNN | Denison Mines Corp | USD 2.16 | ▼ 7.3% |
| UROY | Uranium Royalty Corp. | USD 3.38 | ▼ 1.17% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:21 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt